Literature DB >> 33000387

Block-and-replace vs. titration antithyroid drug regimen for Graves' hyperthyroidism: two is not always better than one.

L H Duntas1.   

Abstract

Entities:  

Keywords:  Block and replace treatment; Hyperthyroidism; Titration regimen

Year:  2020        PMID： 33000387     DOI： 10.1007/s40618-020-01431-1

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  15 in total

1.  Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.

Authors:  Peter Laurberg; Dalia C Berman; Stig Andersen; Inge Bülow Pedersen
Journal:  Thyroid       Date:  2011-08-11       Impact factor: 6.568

2.  Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.

Authors:  M Žarković; W Wiersinga; P Perros; L Bartalena; S Donati; O Okosieme; D Morris; N Fichter; J Lareida; C Daumerie; M-C Burlacu; G J Kahaly; S Pitz; B Beleslin; J Ćirić; G Ayvaz; O Konuk; F B Törüner; M Salvi; D Covelli; N Curro; L Hegedüs; T Brix
Journal:  J Endocrinol Invest       Date:  2020-06-10       Impact factor: 4.256

Review 3.  Antithyroid drugs.

Authors:  David S Cooper
Journal:  N Engl J Med       Date:  2005-03-03       Impact factor: 91.245

Review 4.  ANNIVERSARY REVIEW: Antithyroid drug therapy: 70 years later

Authors:  Henry B Burch; David S Cooper
Journal:  Eur J Endocrinol       Date:  2018-10-12       Impact factor: 6.664

5.  Treatment of Graves' disease with the block-replace regimen of antithyroid drugs: the effect of treatment duration and immunogenetic susceptibility on relapse.

Authors:  A P Weetman; A P Pickerill; P Watson; V K Chatterjee; O M Edwards
Journal:  Q J Med       Date:  1994-06

6.  Landmark article May 8, 1943: Treatment of hyperthyroidism with thiourea and thiouracil. By E.B. Astwood.

Authors:  E B Astwood
Journal:  JAMA       Date:  1984-04-06       Impact factor: 56.272

7.  Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease.

Authors:  N Mitsiades; V Poulaki; S Tseleni-Balafouta; G P Chrousos; D A Koutras
Journal:  Thyroid       Date:  2000-07       Impact factor: 6.568

8.  Single dose, "block-replace" drug therapy in hyperthyroidism.

Authors:  P H Wise; M Marion; R W Pain
Journal:  Br Med J       Date:  1973-10-20

9.  Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.

Authors:  K Hashizume; K Ichikawa; A Sakurai; S Suzuki; T Takeda; M Kobayashi; T Miyamoto; M Arai; T Nagasawa
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

10.  Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.

Authors:  T H Tötterman; F A Karlsson; M Bengtsson; I Mendel-Hartvig
Journal:  N Engl J Med       Date:  1987-01-01       Impact factor: 91.245
View more
  1 in total

Review 1.  COVID-19 and Thyroid Diseases: A Bidirectional Impact.

Authors:  Leonidas H Duntas; Jacqueline Jonklaas
Journal:  J Endocr Soc       Date:  2021-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.